Amanda van Vliet

3PUBLICATIONS
5CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 06, 2023
Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and metastatic colorectal cancer.

Elisa C Toffoli, Amanda A van Vliet, Henk W M Verheul

|Nov 13, 2021
Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor.

Elisa C Toffoli, Abdolkarim Sheikhi, Roeland Lameris

|Sep 28, 2021
Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma.

Amanda A van Vliet, Anna-Maria Georgoudaki, Monica Raimo

Pageof 1

Frequent Collaborators

2 joint publications

Elisa C Toffoli

1 joint publications

Abdolkarim Sheikhi

1 joint publications

Bruce Walcheck

1 joint publications

Henk M W Verheul